{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:04:48Z","timestamp":1788588288241,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64005-w","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:00:34Z","timestamp":1759917634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus"],"prefix":"10.1038","volume":"16","author":[{"given":"Dandan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7537-2789","authenticated-orcid":false,"given":"Zixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-6669","authenticated-orcid":false,"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9364-8572","authenticated-orcid":false,"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-7404","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-9334","authenticated-orcid":false,"given":"Gong-Hong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"64005_CR1","doi-asserted-by":"crossref","unstructured":"Bray F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74, 229-263 (2024).","DOI":"10.3322\/caac.21834"},{"key":"64005_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F. & Jemal, A. Recent global patterns in prostate cancer incidence and mortality rates. Eur. Urol. 77, 38\u201352 (2020).","journal-title":"Eur. Urol."},{"key":"64005_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ijc.29894","volume":"138","author":"CK Zhou","year":"2016","unstructured":"Zhou, C. K. et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J. Cancer 138, 1388\u20131400 (2016).","journal-title":"Int J. Cancer"},{"key":"64005_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","volume":"61","author":"MM Center","year":"2012","unstructured":"Center, M. M. et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 61, 1079\u20131092 (2012).","journal-title":"Eur. Urol."},{"key":"64005_CR5","doi-asserted-by":"publisher","first-page":"k3581","DOI":"10.1136\/bmj.k3581","volume":"362","author":"KAO Tikkinen","year":"2018","unstructured":"Tikkinen, K. A. O. et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline. BMJ 362, k3581 (2018).","journal-title":"BMJ"},{"key":"64005_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.eururo.2016.05.043","volume":"70","author":"MC Wong","year":"2016","unstructured":"Wong, M. C. et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur. Urol. 70, 862\u2013874 (2016).","journal-title":"Eur. Urol."},{"key":"64005_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7326\/M16-2586","volume":"167","author":"A Tsodikov","year":"2017","unstructured":"Tsodikov, A. et al. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO Trials. Ann. Intern Med 167, 449\u2013455 (2017).","journal-title":"Ann. Intern Med"},{"key":"64005_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu, S. et al. Prostate cancer. Lancet 398, 1075\u20131090 (2021).","journal-title":"Lancet"},{"key":"64005_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34994-z","volume":"13","author":"N Giannareas","year":"2022","unstructured":"Giannareas, N. et al. Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG. Nat. Commun. 13, 7320 (2022).","journal-title":"Nat. Commun."},{"key":"64005_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1046","volume":"27","author":"S Benafif","year":"2018","unstructured":"Benafif, S., Kote-Jarai, Z., Eeles, R. A. & Consortium, P. A review of prostate cancer genome-wide association studies (GWAS). Cancer Epidemiol. Biomark. Prev. 27, 845\u2013857 (2018).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"64005_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jama.2015.17703","volume":"315","author":"LA Mucci","year":"2016","unstructured":"Mucci, L. A. et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA 315, 68\u201376 (2016).","journal-title":"JAMA"},{"key":"64005_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ng1999","volume":"39","author":"J Gudmundsson","year":"2007","unstructured":"Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet 39, 631\u2013637 (2007).","journal-title":"Nat. Genet"},{"key":"64005_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.canlet.2021.09.025","volume":"522","author":"P Tian","year":"2021","unstructured":"Tian, P., Zhong, M. & Wei, G. H. Mechanistic insights into genetic susceptibility to prostate cancer. Cancer Lett. 522, 155\u2013163 (2021).","journal-title":"Cancer Lett."},{"key":"64005_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","volume":"53","author":"DV Conti","year":"2021","unstructured":"Conti, D. V. et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat. Genet 53, 65\u201375 (2021).","journal-title":"Nat. Genet"},{"key":"64005_CR15","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang, A. et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat. Genet 55, 2065\u20132074 (2023).","journal-title":"Nat. Genet"},{"key":"64005_CR16","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1073\/pnas.1200853109","volume":"109","author":"C Grisanzio","year":"2012","unstructured":"Grisanzio, C. et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc. Natl. Acad. Sci. USA 109, 11252\u201311257 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64005_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41568-018-0087-3","volume":"19","author":"S Farashi","year":"2019","unstructured":"Farashi, S., Kryza, T., Clements, J. & Batra, J. Post-GWAS in prostate cancer: from genetic association to biological contribution. Nat. Rev. Cancer 19, 46\u201359 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"64005_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ng.840","volume":"43","author":"ML Freedman","year":"2011","unstructured":"Freedman, M. L. et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat. Genet 43, 513\u2013518 (2011).","journal-title":"Nat. Genet"},{"key":"64005_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ajhg.2013.10.012","volume":"93","author":"SL Edwards","year":"2013","unstructured":"Edwards, S. L., Beesley, J., French, J. D. & Dunning, A. M. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet 93, 779\u2013797 (2013).","journal-title":"Am. J. Hum. Genet"},{"key":"64005_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-S8-S9","volume":"14","author":"J Jiang","year":"2013","unstructured":"Jiang, J., Cui, W., Vongsangnak, W., Hu, G. & Shen, B. Post genome-wide association studies functional characterization of prostate cancer risk loci. BMC Genomics 14, S9 (2013).","journal-title":"BMC Genomics"},{"key":"64005_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ajhg.2018.04.002","volume":"102","author":"MD Gallagher","year":"2018","unstructured":"Gallagher, M. D. & Chen-Plotkin, A. S. The post-GWAS Era: from association to function. Am. J. Hum. Genet 102, 717\u2013730 (2018).","journal-title":"Am. J. Hum. Genet"},{"key":"64005_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.2137","volume":"30","author":"A Melnikov","year":"2012","unstructured":"Melnikov, A. et al. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat. Biotechnol. 30, 271\u2013277 (2012).","journal-title":"Nat. Biotechnol."},{"key":"64005_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25514-6","volume":"12","author":"S Khetan","year":"2021","unstructured":"Khetan, S. et al. Functional characterization of T2D-associated SNP effects on baseline and ER stress-responsive beta cell transcriptional activation. Nat. Commun. 12, 5242 (2021).","journal-title":"Nat. Commun."},{"key":"64005_CR24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1232542","volume":"339","author":"CD Arnold","year":"2013","unstructured":"Arnold, C. D. et al. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339, 1074\u20131077 (2013).","journal-title":"Science"},{"key":"64005_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1322-z","volume":"18","author":"S Liu","year":"2017","unstructured":"Liu, S. et al. Systematic identification of regulatory variants associated with cancer risk. Genome Biol. 18, 194 (2017).","journal-title":"Genome Biol."},{"key":"64005_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.aag2445","volume":"354","author":"CP Fulco","year":"2016","unstructured":"Fulco, C. P. et al. Systematic mapping of functional enhancer-promoter connections with CRISPR interference. Science 354, 769\u2013773 (2016).","journal-title":"Science"},{"key":"64005_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21867-0","volume":"12","author":"M Ahmed","year":"2021","unstructured":"Ahmed, M. et al. CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer. Nat. Commun. 12, 1781 (2021).","journal-title":"Nat. Commun."},{"key":"64005_CR28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cell.2016.03.041","volume":"165","author":"AK Tehranchi","year":"2016","unstructured":"Tehranchi, A. K. et al. Pooled ChIP-Seq links variation in transcription factor binding to complex disease risk. Cell 165, 730\u2013741 (2016).","journal-title":"Cell"},{"key":"64005_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04451-x","volume":"9","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing. Nat. Commun. 9, 2022 (2018).","journal-title":"Nat. Commun."},{"key":"64005_CR30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41588-018-0159-z","volume":"50","author":"G Li","year":"2018","unstructured":"Li, G. et al. High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. Nat. Genet 50, 1180\u20131188 (2018).","journal-title":"Nat. Genet"},{"key":"64005_CR31","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ng.3094","volume":"46","author":"AA Al Olama","year":"2014","unstructured":"Al Olama, A. A. et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat. Genet 46, 1103\u20131109 (2014).","journal-title":"Nat. Genet"},{"key":"64005_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher, F. R. et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet 50, 928\u2013936 (2018).","journal-title":"Nat. Genet"},{"key":"64005_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li, J. et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature 580, 93\u201399 (2020).","journal-title":"Nature"},{"key":"64005_CR34","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.xpro.2021.100419","volume":"2","author":"P Gao","year":"2021","unstructured":"Gao, P., Dong, X., Wang, Y. & Wei, G. H. Optimized CRISPR\/Cas9-mediated single nucleotide mutation in adherent cancer cell lines. STAR Protoc. 2, 100419 (2021).","journal-title":"STAR Protoc."},{"key":"64005_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41587-022-01595-6","volume":"41","author":"H Tong","year":"2023","unstructured":"Tong, H. et al. Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase. Nat. Biotechnol. 41, 1080\u20131084 (2023).","journal-title":"Nat. Biotechnol."},{"key":"64005_CR36","unstructured":"The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate.\u00a0Cell 163, 1011\u20131025 (2015)."},{"key":"64005_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1055-9965.EPI-14-0694-T","volume":"24","author":"KL Penney","year":"2015","unstructured":"Penney, K. L. et al. Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiol. Biomark. Prev. 24, 255\u2013260 (2015).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"64005_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12298-z","volume":"10","author":"DP Labbe","year":"2019","unstructured":"Labbe, D. P. et al. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program. Nat. Commun. 10, 4358 (2019).","journal-title":"Nat. Commun."},{"key":"64005_CR39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/cr.2012.30","volume":"22","author":"S Ren","year":"2012","unstructured":"Ren, S. et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 22, 806\u2013821 (2012).","journal-title":"Cell Res"},{"key":"64005_CR40","doi-asserted-by":"publisher","first-page":"1762473","DOI":"10.1080\/2162402X.2020.1762473","volume":"9","author":"N Shao","year":"2020","unstructured":"Shao, N. et al. A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer. Oncoimmunology 9, 1762473 (2020).","journal-title":"Oncoimmunology"},{"key":"64005_CR41","doi-asserted-by":"publisher","first-page":"e2318","DOI":"10.1371\/journal.pone.0002318","volume":"3","author":"T Nakagawa","year":"2008","unstructured":"Nakagawa, T. et al. A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One 3, e2318 (2008).","journal-title":"PLoS One"},{"key":"64005_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"64005_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239\u2013243 (2012).","journal-title":"Nature"},{"key":"64005_CR44","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ccell.2023.06.010","volume":"41","author":"X Li","year":"2023","unstructured":"Li, X. et al. Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. Cancer Cell 41, 1427\u20131449 (2023).","journal-title":"Cancer Cell"},{"key":"64005_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41422-024-01025-z","volume":"35","author":"F Li","year":"2025","unstructured":"Li, F. et al. LKB1 inactivation promotes epigenetic remodeling-induced lineage plasticity and antiandrogen resistance in prostate cancer. Cell Res 35, 59\u201371 (2025).","journal-title":"Cell Res"},{"key":"64005_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298\u2013305 (2016).","journal-title":"Nat. Med."},{"key":"64005_CR47","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.eururo.2017.08.027","volume":"73","author":"S Ren","year":"2018","unstructured":"Ren, S. et al. Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression. Eur. Urol. 73, 322\u2013339 (2018).","journal-title":"Eur. Urol."},{"key":"64005_CR48","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl. Acad. Sci. USA 116, 11428\u201311436 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64005_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nm.4053","volume":"22","author":"A Kumar","year":"2016","unstructured":"Kumar, A. et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat. Med 22, 369\u2013378 (2016).","journal-title":"Nat. Med"},{"key":"64005_CR50","doi-asserted-by":"crossref","unstructured":"Deplancke, B., Alpern, D. & Gardeux, V. The Genetics of Transcription Factor DNA Binding Variation. Cell 166, 538\u2013554 (2016).","DOI":"10.1016\/j.cell.2016.07.012"},{"key":"64005_CR51","doi-asserted-by":"crossref","unstructured":"Butter, F. et al. Proteome-wide analysis of disease-associated SNPs that show allele-specific transcription factor binding. PLoS Genet 8, e1002982 (2012).","DOI":"10.1371\/journal.pgen.1002982"},{"key":"64005_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2005.10.042","volume":"124","author":"O Hallikas","year":"2006","unstructured":"Hallikas, O. et al. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124, 47\u201359 (2006).","journal-title":"Cell"},{"key":"64005_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cell.2012.12.009","volume":"152","author":"A Jolma","year":"2013","unstructured":"Jolma, A. et al. DNA-binding specificities of human transcription factors. Cell 152, 327\u2013339 (2013).","journal-title":"Cell"},{"key":"64005_CR54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet 45, 580\u2013585 (2013).","journal-title":"Nat. Genet"},{"key":"64005_CR55","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","volume":"2","author":"H Ross-Adams","year":"2015","unstructured":"Ross-Adams, H. et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine 2, 1133\u20131144 (2015).","journal-title":"EBioMedicine"},{"key":"64005_CR56","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller, J. H. Targeting transcription factors in cancer - from undruggable to reality. Nat. Rev. Cancer 19, 611\u2013624 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"64005_CR57","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser, C. et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34, 996\u20131011 e1018 (2018).","journal-title":"Cancer Cell"},{"key":"64005_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrc.2017.82","volume":"17","author":"A Sud","year":"2017","unstructured":"Sud, A., Kinnersley, B. & Houlston, R. S. Genome-wide association studies of cancer: current insights and future perspectives. Nat. Rev. Cancer 17, 692\u2013704 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"64005_CR59","doi-asserted-by":"crossref","unstructured":"Uffelmann E. et al. Genome-wide association studies. Nat. Rev. Method Prime 1, 59 (2021).","DOI":"10.1038\/s43586-021-00056-9"},{"key":"64005_CR60","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam, V. et al. Benefits and limitations of genome-wide association studies. Nat. Rev. Genet 20, 467\u2013484 (2019).","journal-title":"Nat. Rev. Genet"},{"key":"64005_CR61","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ng.3094","volume":"46","author":"AA Al Olama","year":"2014","unstructured":"Al Olama, A. A. et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat. Genet. 46, 1103\u20131109 (2014).","journal-title":"Nat. Genet."},{"key":"64005_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","volume":"27","author":"TR Rebbeck","year":"2017","unstructured":"Rebbeck, T. R. Prostate cancer genetics: variation by race, ethnicity, and geography. Semin Radiat. Oncol. 27, 3\u201310 (2017).","journal-title":"Semin Radiat. Oncol."},{"key":"64005_CR63","doi-asserted-by":"crossref","unstructured":"Dias A., Kote-Jarai Z., Mikropoulos C., Eeles R. Prostate Cancer Germline Variations and Implications for Screening and Treatment. Cold Spring Harb Perspect Med. 8, a030379 (2018).","DOI":"10.1101\/cshperspect.a030379"},{"key":"64005_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04109-8","volume":"9","author":"T Dadaev","year":"2018","unstructured":"Dadaev, T. et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nat. Commun. 9, 2256 (2018).","journal-title":"Nat. Commun."},{"key":"64005_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40616-z","volume":"14","author":"S Spisak","year":"2023","unstructured":"Spisak, S. et al. A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. Nat. Commun. 14, 5118 (2023).","journal-title":"Nat. Commun."},{"key":"64005_CR66","doi-asserted-by":"crossref","unstructured":"Prokop J. W. et al. Emerging role of ODC1 in neurodevelopmental disorders and brain development. Genes (Basel) 12, 470 (2021).","DOI":"10.3390\/genes12040470"},{"key":"64005_CR67","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41586-022-05275-y","volume":"610","author":"L Yengo","year":"2022","unstructured":"Yengo, L. et al. A saturated map of common genetic variants associated with human height. Nature 610, 704\u2013712 (2022).","journal-title":"Nature"},{"key":"64005_CR68","doi-asserted-by":"publisher","first-page":"967082","DOI":"10.3389\/fphar.2022.967082","volume":"13","author":"IG Asiimwe","year":"2022","unstructured":"Asiimwe, I. G. et al. A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients. Front Pharm. 13, 967082 (2022).","journal-title":"Front Pharm."},{"key":"64005_CR69","doi-asserted-by":"publisher","first-page":"D181","DOI":"10.1093\/nar\/gkn804","volume":"37","author":"Y Ahmad","year":"2009","unstructured":"Ahmad, Y., Boisvert, F. M., Gregor, P., Cobley, A. & Lamond, A. I. NOPdb: nucleolar proteome database-\u22122008 update. Nucleic acids Res. 37, D181\u2013D184 (2009).","journal-title":"Nucleic acids Res."},{"key":"64005_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35602-w","volume":"14","author":"X Jin","year":"2023","unstructured":"Jin, X. et al. PQBP5\/NOL10 maintains and anchors the nucleolus under physiological and osmotic stress conditions. Nat. Commun. 14, 9 (2023).","journal-title":"Nat. Commun."},{"key":"64005_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-1900-2","volume":"9","author":"M Schubert","year":"2016","unstructured":"Schubert, M., Lindgreen, S. & Orlando, L. AdapterRemoval v2: rapid adapter trimming, identification, and read merging. BMC Res Notes 9, 88 (2016).","journal-title":"BMC Res Notes"},{"key":"64005_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"64005_CR73","doi-asserted-by":"crossref","unstructured":"Danecek P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"64005_CR74","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"64005_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"64005_CR76","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb.) 2, 100141 (2021).","journal-title":"Innov. (Camb.)"},{"key":"64005_CR77","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"64005_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"64005_CR79","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers, L. A. et al. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin. Cancer Res 19, 279\u2013290 (2013).","journal-title":"Clin. Cancer Res"},{"key":"64005_CR80","doi-asserted-by":"crossref","unstructured":"Giannareas N. et al. Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG. Nat. Commun. 13, 7320 (2022).","DOI":"10.1038\/s41467-022-34994-z"},{"key":"64005_CR81","doi-asserted-by":"crossref","unstructured":"Chen Y. et al. Multi-factors including inflammatory\/immune, hormones, tumor-related proteins and nutrition associated with chronic prostatitis NIH IIIa plus b and IV based on project. Sci. Rep-Uk 7, 9143 (2017).","DOI":"10.1038\/s41598-017-09751-8"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64005-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:03:22Z","timestamp":1759921402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64005-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64005"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64005-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3943095\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8950"}}